ASCO GU24 special: Prof. Michael Hofman talks about a novel CA IX-targeting peptide

(6:38)

Dr. Silke Gillessen Invites You to Submit to ASCO #GU24

(42)

Dr. Todd Morgan on Why You Should Submit to ASCO #GU24

(33)

Dr. Silke Gillessen Invites You to Attend ASCO #GU24

(47)

ASCO GU24 special: Dr. Andrea Apolo shares AMBASSADOR results

(8:19)

ASCO GU24 special: Assoc. Prof. Barata discusses the results of KEYNOTE-564 and CheckMate-914

(10:51)

ASCO GU24 special: Dr. Kim Chi discusses CONTACT-2 results

(5:)

ASCO GU24 special: Prof. Christophe Hennequin on GETUG-AFU 18 trial results

(3:38)

ASCO GU24 special: Prof. Nizar Tannir shares CheckMate 214 results

(13:10)

What Does Gleason 9 \u0026 10 Mean? | Ask a Prostate Expert, Mark Scholz, MD

(3:4)

Gleason 3+4=7 and 4+3=7: What Is The Difference? | Ask a Prostate Expert, Mark Scholz, MD

(4:28)

Panel Discussion ASCO GU 22 - bit spicy

(2:30)

ASCO #GU24: Alok Tewari, MD, PhD | Dana-Farber Cancer Institute

(2:23)

ASCO #GU24 Celebrates 20 Years!

(4:15)

ASCO GU Research to Watch: Prostate Cancer

(3:32)

Have you watched our three-episode series on ASCO #GU24 yet?

(41)

What’s New in Prostate Cancer, RCC, and mUC at GU24

(25:10)

ASCO GU Research to Watch: Kidney Cancer

(3:18)

Episode 1: ASCO GU 2024 Commentary: Prostate Cancer - The View on GU | with Lalani \u0026 Wallis

(31:14)

2022 ASCO GU Cancers Symposium Keynote | A Path Forward: Addressing Disparities in GU Cancers

(29:57)

Key Advances in Prostate, Kidney, and Bladder Cancers at GU24

(30:25)

2020 ASCO-GU Prostate Cancer Update | Ask a Prostate Cancer Expert

(6:9)